News | Magnetic Resonance Imaging (MRI) | October 06, 2025

PULSE platform empowers Swoop system users worldwide to access advanced tools in support of imaging research and clinical studies in portable MRI.

 

Hyperfine Introduces Subscription-Based Platform to Accelerate Adoption of AI-Powered Portable MRI

Oct. 6, 2025 — Hyperfine, Inc. has launched the Portable Ultra-Low-Field Scientific Exchange (PULSE), a subscription-based platform designed to empower a global community of clinical researchers and developers advancing access and innovation in portable MRI.

Hyperfine is the developer of the first FDA-cleared AI-powered portable MRI system for the brain the Swoop system

Available to all Swoop AI-powered portable MRI system users, the PULSE subscription provides access to innovative tools that empower both clinical researchers and developers to advance the rapidly growing field of portable MRI. Subscribers gain access to proprietary Hyperfine research sequences powered by Optive AI software, can import and adapt community-developed sequences, and can access raw data to support diverse imaging initiatives. PULSE enables researchers to explore new clinical applications, while giving developers the foundation to prototype, test, and deploy next-generation imaging solutions. By bringing research capabilities into everyday clinical practice, PULSE enables research and innovation across specialties such as neurology, pediatrics, emergency medicine, neurosurgery, and underserved care.

“PULSE transforms the Swoop® system from a clinical device into an innovation platform,” said Maria Sainz, President and CEO of Hyperfine, Inc. “Through unprecedented access to our technology and collaborative support, we’re creating new opportunities for clinical researchers and developers to help advance the next wave of portable MRI technology. We look forward to partnering with PULSE subscribers to further accelerate the revolutionary potential of portable MRI.”

PULSE is now available via subscription to all Swoop system users. The platform includes a curated suite of tools as well as opportunities for advanced technical support. In future phases, Hyperfine plans to expand access to application developers without physical access to the Swoop® system, extending the impact of the program across academic institutions, startups, and AI innovators.

For more information about the Swoop system, please visit HyperfineMRI.com.


Related Content

News | Ultrasound Women's Health

Feb. 5, 2026 — BrightHeart, a global provider of AI-driven prenatal ultrasound, has announced the availability of its B ...

Time February 05, 2026
arrow
News | Lung Imaging

Feb. 3, 2026 — RevealDx, a leader in the characterization of lung nodules, recently announced FDA clearance of RevealAI ...

Time February 04, 2026
arrow
News | FDA

Jan. 29, 2026 — GE HealthCare has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for MIM ...

Time February 03, 2026
arrow
News | Radiology Education

Jan. 22, 2026—The American Roentgen Ray Society (ARRS) will host a live virtual symposium, "Medical Imaging for ...

Time January 28, 2026
arrow
News | Radiology Imaging

Jan.26, 2026 — SimonMed Imaging has unveiled an updated brand and the launch of SimonMed Longevity, a new division ...

Time January 27, 2026
arrow
News | Point-of-Care Ultrasound (POCUS)

Jan. 22, 2026 — Qure.ai has received a grant from the Gates Foundation to develop a large open-source multi-modal ...

Time January 23, 2026
arrow
News | Magnetic Resonance Imaging (MRI)

Jan. 20, 2026 — Hyperfine, the developer of the first FDA-cleared AI-powered portable MRI system for the brain — the ...

Time January 20, 2026
arrow
News | Mammography

Jan. 16, 2026 — Vega Imaging Informatics has announced the successful curation of the world’s largest digital breast ...

Time January 19, 2026
arrow
News | Radiation Therapy

Jan. 16, 2026 — Elekta has announced that its Elekta Evo* CT-Linac has received 510(k) clearance from the U.S. Food and ...

Time January 16, 2026
arrow
News | Stroke

Dec. 18, 2025 — Brainomix, a provider of AI-powered imaging biomarkers for stroke and lung fibrosis, has announced ...

Time December 24, 2025
arrow
Subscribe Now